SEI Investments' Global Funds Services unit has unveiled a mutual fund diagnostic tool, Product Analysis, to help its clients better market their wares. The new product is designed to help clients understand their mutual funds' competitive strengths and weaknesses using statistical information and benchmarking tools. It also provides insight into the product's investment management through use of attribution testing and analysis.

"Understanding the competitive landscape is essential in evaluating growth opportunities and distribution strategies," explained Ross Ellis, vice president of SEI and head of Global Funds Services. "We're not just gathering essential data. SEI's real value-added is making our market research actionable. We believe our new diagnostic tool delivers on that goal."

SEI developed the product with Union Bank of California (UBOC) and the Bank's proprietary HighMark mutual fund business.

"SEI's Product Analysis for our HighMark Funds is an eminently useful and client-centric analysis," said Earle A. Malm II, president and CEO of HighMark Capital Management, a wholly owned subsidiary of UBOC. "Using results of the diagnostic, HighMark Capital has been helpful in communicating with both portfolio managers and providing insights to the Board of Directors of the fund complex."

Moreover, SEI plans to roll out a second generation version of its distribution diagnostic to clients, while the third diagnostic tool in the suite, one dealing with wholesaling activities, is expected to be launched later this year. 

Stay ahead of the news ... Sign up for our email alerts now
CLICK HERE